LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Malaria Protection Linked to Receptor Mutations

By LabMedica International staff writers
Posted on 29 May 2017
Image: A photomicrograph of a blood smear containing a macro- and microgametocyte of the Plasmodium falciparum parasite (Photo courtesy of the CDC).
Image: A photomicrograph of a blood smear containing a macro- and microgametocyte of the Plasmodium falciparum parasite (Photo courtesy of the CDC).
Resistance to malaria in some parts of Africa has been linked to mutations in the genes that code for the glycophorin receptors on the surface of the red blood cells that are attacked and invaded by the parasite.

The malaria parasite Plasmodium falciparum invades human red blood cells via interactions between host and parasite surface proteins. To better understand these interactions, an international research conglomerate - coordinated by the Wellcome Trust Sanger Institute - investigated the glycophorin area of the genome in more detail than ever before using new whole-genome sequence data from healthy and ill volunteers in the Gambia, Burkina Faso, Cameroon, and Tanzania.

The investigators reported in the May 18, 2017, online edition of the journal Science that they had identified a diverse array of large copy number variants affecting the host invasion receptor genes GYPA (Glycophorin A) and GYPB (Glycophorin B). They found that a nearby association with severe malaria was explained by a complex structural rearrangement involving the loss of GYPB and gain of two GYPB-A hybrid genes, which encoded a serologically distinct blood group antigen known as Dantu.

Dantu is a minor member of the MNS human blood group system, which is a based on the two glycophorin genes on chromosome four. There are 46 antigens in the system; the most common are called M, N, S, s, and U. The Dantu variant reduces the risk of severe malaria by 40% and has recently risen in frequency in parts of Kenya, yet it appears to be absent from West Africa.

Senior author Dr. Dominic Kwiatkowski, professor of tropical pediatrics at the Wellcome Trust Sanger Institute, said, "We are starting to find that the glycophorin region of the genome has an important role in protecting people against malaria. Our discovery that a specific variant of glycophorin invasion receptors can give substantial protection against severe malaria will hopefully inspire further research on exactly how Plasmodium falciparum invade red blood cells. This could also help us discover novel parasite weaknesses that could be exploited in future interventions against this deadly disease."

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more